A1/A2A adenosine receptor antagonists (University of Bonn)

N/A

Report date: 2025/01/26 19:34:11
NME

Base Information

Drug NameA1/A2A adenosine receptor antagonists (University of Bonn)
Drug Alias NameALXAN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bonn
China Registration ClassN/A

Develop Information

Active CompaniesPROvendis GmbHUniversity Of Bonn
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A